Cargando…

Small-Fiber-Neuropathien

Small fiber neuropathy (SFN) is a disease of the peripheral nervous system characterized by isolated or predominant damage to the thinly myelinated Aδ-fibers and/or the unmyelinated C‑fibers. In addition to the clinical symptoms of pain and sensory disturbances that are typically more pronounced dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Sachau, J., Enax-Krumova, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559077/
http://dx.doi.org/10.1007/s42451-022-00488-x
_version_ 1784807582643257344
author Sachau, J.
Enax-Krumova, E.
author_facet Sachau, J.
Enax-Krumova, E.
author_sort Sachau, J.
collection PubMed
description Small fiber neuropathy (SFN) is a disease of the peripheral nervous system characterized by isolated or predominant damage to the thinly myelinated Aδ-fibers and/or the unmyelinated C‑fibers. In addition to the clinical symptoms of pain and sensory disturbances that are typically more pronounced distally, the reliable diagnosis of SFN requires evidence of rarefication or dysfunction of the thinly myelinated Aδ-fibers and/or unmyelinated C‑fibers. The present article provides an overview of the diagnostic procedures for detecting SFN, its possible underlying causes, as well as the available treatment options.
format Online
Article
Text
id pubmed-9559077
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-95590772022-10-14 Small-Fiber-Neuropathien Sachau, J. Enax-Krumova, E. DGNeurologie CME Zertifizierte Fortbildung Small fiber neuropathy (SFN) is a disease of the peripheral nervous system characterized by isolated or predominant damage to the thinly myelinated Aδ-fibers and/or the unmyelinated C‑fibers. In addition to the clinical symptoms of pain and sensory disturbances that are typically more pronounced distally, the reliable diagnosis of SFN requires evidence of rarefication or dysfunction of the thinly myelinated Aδ-fibers and/or unmyelinated C‑fibers. The present article provides an overview of the diagnostic procedures for detecting SFN, its possible underlying causes, as well as the available treatment options. Springer Medizin 2022-10-13 2022 /pmc/articles/PMC9559077/ http://dx.doi.org/10.1007/s42451-022-00488-x Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle CME Zertifizierte Fortbildung
Sachau, J.
Enax-Krumova, E.
Small-Fiber-Neuropathien
title Small-Fiber-Neuropathien
title_full Small-Fiber-Neuropathien
title_fullStr Small-Fiber-Neuropathien
title_full_unstemmed Small-Fiber-Neuropathien
title_short Small-Fiber-Neuropathien
title_sort small-fiber-neuropathien
topic CME Zertifizierte Fortbildung
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559077/
http://dx.doi.org/10.1007/s42451-022-00488-x
work_keys_str_mv AT sachauj smallfiberneuropathien
AT enaxkrumovae smallfiberneuropathien